BridgeBio Pharma, Inc. (BBIO)
68.15
+0.06
(+0.09%)
USD |
NASDAQ |
May 07, 12:02
BridgeBio Pharma SG&A Expense (TTM) : 531.22M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Pfizer Inc. | 10.76B |
| Mirum Pharmaceuticals, Inc. | 257.03M |
| Insmed, Inc. | 701.17M |
| Eli Lilly & Co. | 11.56B |
| Alnylam Pharmaceuticals, Inc. | 1.293B |